However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...

A research team affiliated with UNIST has made a significant breakthrough in sustainable technology through the development ...

Learn how to build your own GPT-style AI model with this step-by-step guide. Demystify large language models and unlock their ...

A drug delivery platform based on peptide coacervate microdroplets offers an avenue for synergistic cancer therapy.

Enzymes catalyze chemical reactions in organisms - without which life would not be possible. Leveraging AlphaFold2 artificial ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

"Each new detection brings us closer to understanding the origins of complex organic chemistry in the universe — and perhaps, ...

Chemical structure verification is a tedious but critical task in the drug discovery and development pipeline. Despite the advances in automation, AI and high-throughput screening that have ...

Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. Quiver AI Summary MIT and Recursion have released Boltz-2 ...

Here, we present a unified study in which de novo small-molecule targeting of a large catalytic RNA was combined with high-resolution structural analysis of the optimized RNA–ligand complex, resulting ...